Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy and DLI for Prevention of Second Relapse in Acute Leukemia
NCT03297528Phase 2Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Mar 2017
- Primary completion
- Oct 2020
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of donor lymphocyte infusion in acute leukemia, sponsored by Peking University People's Hospital. Primary endpoint: Number of participants with a positive results of minimal residual disease at 1 year. Status: unknown.
02
Drugs
donor lymphocyte infusion
03
Conditions
acute leukemia
Beyond the preview
Go deeper on NCT03297528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03297528.